The objective of this live training webinar is to develop an understanding of how a compliant laboratory handles the investigation of OOS test observations and how the laboratory interfaces with other units through the laboratory investigation process. The interactive live discussion will be based on the FDA guidance on handling OOS laboratory results and to provide a clear process for compliant laboratory OOS investigations.
Agenda
The requirements for laboratory OOS investigations- Latest Regulatory expectations.
- The laboratory OOS investigation process.
- Laboratory investigation, Phase I.
- Laboratory investigation, Phase II.
- Retesting.
- Resampling.
- Communicating with Quality Assurance.
- Understand the developing expectation for appropriate OOS investigations.
- Understand of the expectation for the identification of the cause of the OOS results.
- Gain a clear insight of the laboratory OOS investigation process.
- Learn the terminology associated with laboratory OOS investigations.
- Learn about outlier testing.
- Understand how the OOS laboratory investigation process relates to the general expectation for deviation investigation.
- US - 21CFR211.160, 192
- ICH Q7; 11.1
- FDA Guidance for the Industry; Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production
Speakers

Kelly Thomas,
Who Should Attend
This webinar will provide a great resource to Pharmaceutical, Biotechnology, Biologics, Drugs, Medical Device, In-vitro Diagnostics Industry personnel within the following functions:- Quality Control
- Quality Assurance
- Microbiologist
- Chemist
- Analysts
- Manufacturing
- Validation
- Facilities
- Materials
- Engineering
- Management


